Trademark Overview
On Friday, June 18, 2021, a trademark application was filed for EPRAXIS with the United States Patent and Trademark Office. The USPTO has given the EPRAXIS trademark a serial number of 90782607. The federal status of this trademark filing is REGISTERED as of Tuesday, August 23, 2022. This trademark is owned by EPRAXIS, LLC. The EPRAXIS trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:
Business education and training services, namely, developing customized in-company leadership and executive development programs, providing executive coaching services; providing public and in-company keynote presentations to business leaders; business education and training services, namely, developing customized leadership and executive development programs, providing executive coaching services, and providing business education programs to employees and executives; career coaching services; professional coaching services in the field of leadership development; providing group coaching and in-person learning forums in the field of leadership development; Peer to peer coaching services in the field of executive leadership for business owners, entrepreneurs, CEOs, presidents, and C-level executives
Talent management services for identifying, exploring, testing, rating, and selecting talent appropriate for high performance in business and workplace settings; talent management services for identifying a color code for essential abilities, acumen, and traits to identify, test, and rate prior to hire; talent recruiting services in the field of business, focusing on identifying key attributes of difference making top talent; management consulting and advisory services in the areas of corporate growth strategy, innovation and growth processes, organizational transformation, and talent management and development strategies; Business networking of peer to peer learning groups for business owners, entrepreneurs, CEOs, presidents, and C-level executives
